Catalyst Wire Dossier Catalyst Wire Dossier

XYZAL ALLERGY 24HR

LEVOCETIRIZINE DIHYDROCHLORIDE · Chattem, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for XYZAL ALLERGY 24HR, covering 2017-01-31 to 2024-07-11. Get the full timeline:

Most recent: FDA Approved: XYZAL ALLERGY 24HR — Supplemental Application (Chattem, Inc.)

See pricing